Verrica Pharmaceuticals Non-GAAP EPS of -$1.24 misses by $0.82, revenue of $35.58M beats by $0.58M
Source: SeekingAlpha
2026-03-11 08:09:30 ET
More on Verrica Pharmaceuticals
- Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals
- Historical earnings data for Verrica Pharmaceuticals
- Financial information for Verrica Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Verrica Pharmaceuticals Non-GAAP EPS of -$1.24 misses by $0.82, revenue of $35.58M beats by $0.58M
Verrica Pharmaceuticals Inc.
NASDAQ: VRCA
VRCA Trading
-2.42% G/L:
$6.085 Last:
101,786 Volume:
$6.16 Open:
VRCA Latest News
March 11, 2026 08:00:00 am
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 08:00:00 am
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
February 23, 2026 08:00:00 am
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
VRCA Stock Data
$98,657,442
3,345,079
4.59%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
West Chester
